ÂÜÀòÂÒÂ×

Brad Rosenblum joined Etiometry in 2021 as Chief Financial Officer with over 25+ years of senior financial management experience. He is the principal owner of a financial consulting firm. Brad has a demonstrated record of building lean, scalable operations, sound financial strategies, and managing cross-functional teams, including operations, sales, and research groups, in executing plans and creating value for stakeholders.

Before joining Etiometry, Brad has worked in various public and private life science and technology organizations. Brad was also the initial CFO for the Massachusetts Life Sciences Center overseeing a portfolio of 40 early-stage companies and managing $650MM in investments. Brad has led or been involved with over 20 mergers, acquisitions, and financings valued at over $500MM.

Brad earned his BBA from the University of Massachusetts, Amherst, an MBA from Boston University, and holds an active CPA license from the Commonwealth of Massachusetts.